PAM
RCUS icon

Panagora Asset Management’s Arcus Biosciences RCUS Stock Holding History

Panagora Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-112,829
Closed -$1.73M – 1233
2024
Q3 		$1.73M Sell
112,829
-132,778
-54% -$2.09M 0.01% 566
2024
Q2 		$3.74M Sell
245,607
-144,692
-37% -$2.34M 0.02% 374
2024
Q1 		$7.37M Buy
390,299
+161,303
+70% +$2.79M 0.04% 277
2023
Q4 		$4.37M Buy
228,996
+129,697
+131% +$2.07M 0.02% 340
2023
Q3 		$1.78M Buy
99,299
+2,107
+2% +$42.3K 0.01% 562
2023
Q2 		$1.97M Sell
97,192
-155,792
-62% -$2.97M 0.01% 543
2023
Q1 		$4.61M Buy
252,984
+55,384
+28% +$1.06M 0.03% 382
2022
Q4 		$4.09M Buy
197,600
+13,466
+7% +$371K 0.03% 424
2022
Q3 		$4.82M Buy
184,134
+6,120
+3% +$162K 0.03% 368
2022
Q2 		$4.51M Buy
178,014
+13,711
+8% +$336K 0.03% 406
2022
Q1 		$5.18M Buy
164,303
+8,684
+6% +$291K 0.03% 409
2021
Q4 		$6.3M Sell
155,619
-30,559
-16% -$1.19M 0.03% 369
2021
Q3 		$6.49M Sell
186,178
-3,276
-2% -$102K 0.03% 378
2021
Q2 		$5.2M Sell
189,454
-2,696
-1% -$77K 0.03% 440
2021
Q1 		$5.4M Buy
192,150
+47,363
+33% +$1.65M 0.03% 447
2020
Q4 		$3.76M Sell
144,787
-3,217
-2% -$77.9K 0.02% 498
2020
Q3 		$2.54M Sell
148,004
-18,885
-11% -$422K 0.02% 556
2020
Q2 		$4.13M Buy
166,889
+122,703
+278% +$3.31M 0.03% 453
2020
Q1 		$613K Buy
44,186
+42,475
+2,482% +$528K ﹤0.01% 1030
2019
Q4 		$17K Buy
1,711
+352
+26% +$2.96K ﹤0.01% 2064
2019
Q3 		$12K Sell
1,359
-67
-5% -$538 ﹤0.01% 2151
2019
Q2 		$11K Buy
+1,426
New +$14.3K ﹤0.01% 2388

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Panagora Asset Management's RCUS Position: Q4 2024 in Review

Panagora Asset Management sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 112,829 shares — an estimated $1.73M sold.

Panagora Asset Management first reported a position in RCUS in Q2 2019 and held it in 22 quarters. The position peaked at $7.37M in Q1 2024. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • Panagora Asset Management reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • Panagora Asset Management sold 112,829 Arcus Biosciences shares in Q4 2024, an estimated $1.73M.
  • Panagora Asset Management first reported a position in Arcus Biosciences in Q2 2019 and held it in 22 quarters.
  • Panagora Asset Management's Arcus Biosciences position peaked at $7.37M in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on Panagora Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.